ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szilagyi, D. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Szilagyi, D. E.

Ann Thorac Surg 1996;62:645
© 1996 The Society of Thoracic Surgeons

Invited Commentary

Invited Commentary

D. Emerick Szilagyi, MD

Division of Vascular Surgery, Henry Ford Hospital, 2799 W Grand Blud, Detroit, MI 48202

The first 20% of the full text of this article appears below.

See also page 640.

The recent revival of interest in the clinical use of arterial allografts is an intriguing phenomenon. As is, or should be, widely known, arterial allografts were the first substitutes used for resected diseased arteries from 1951 to 1955, but their use was discontinued because of their prohibitively frequent structural failure.

Yet, this generally highly disappointing early experience shed some rays of hope for possible success, a . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1996 by The Society of Thoracic Surgeons.